Regeneron Pharmaceuticals Operating Margin

REGN -- USA Stock  

USD 279.06  2.56  0.91%

Regeneron Pharmaceuticals operating-margin fundamental analysis lookup allows you to check this and other indicators for Regeneron Pharmaceuticals or any other equity instrument. You can also select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please check also Equity Screeners to view more equity screening tools

Regeneron Pharmaceuticals Operating Margin Analysis

Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Operating Margin 
Operating Income 
More About Operating Margin | All Equity Analysis
Regeneron Pharmaceuticals Operating Margin  =
Regeneron Pharmaceuticals ValuationFundamentalsBuy or Sell

Regeneron Pharmaceuticals Operating Margin Over Time Pattern

 Regeneron Pharmaceuticals Operating Margin 

About Operating Margin

A good Operating Margin is required for a company to be able to pay for its fixed costs or pay out its debt which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against firm's competitors.
Compare to competition
Accumulated Other Comprehensive Income
Based on recorded statements Regeneron Pharmaceuticals has Operating Margin of 32.08%. This is 191.45% lower than that of the Healthcare sector, and 128.62% lower than that of Biotechnology industry, The Operating Margin for all stocks is 682.21% lower than the firm.

Did you try this?

Run Aroon Oscillator Now


Aroon Oscillator

Analyze current equity momentum using Aroon Oscillator and other momentum ratios
All  Next Launch Module

Regeneron Pharmaceuticals current financial ratios